The advent of micro-invasive glaucoma surgery (MIGS), offers numerous benefits to patients. However, ODs must engage in good communication with the cataract surgeon and glaucoma surgeon to determine which MIGS procedure will render the best outcome, reports Marc R. Bloomenstein, OD, FAAO.
Corneal filaments frequently recur after removal, and resolution occurs only by treating the patient’s underlying inflammation. This case illustrates the need to move to atypical therapies, such as N-acetylcysteine.
This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.
This email was sent by: %%Member_Busname%% %%Member_Addr%% %%Member_City%%, %%Member_State%%, %%Member_PostalCode%%, %%Member_Country%%
